GB9903664D0 - Adjuvant and cell maturation agent - Google Patents

Adjuvant and cell maturation agent

Info

Publication number
GB9903664D0
GB9903664D0 GBGB9903664.2A GB9903664A GB9903664D0 GB 9903664 D0 GB9903664 D0 GB 9903664D0 GB 9903664 A GB9903664 A GB 9903664A GB 9903664 D0 GB9903664 D0 GB 9903664D0
Authority
GB
United Kingdom
Prior art keywords
adjuvant
cell maturation
maturation agent
agent
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9903664.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB9903664.2A priority Critical patent/GB9903664D0/en
Publication of GB9903664D0 publication Critical patent/GB9903664D0/en
Priority to CA002362783A priority patent/CA2362783A1/en
Priority to EP00903870A priority patent/EP1152771A2/en
Priority to PCT/GB2000/000559 priority patent/WO2000048631A2/en
Priority to AU25623/00A priority patent/AU2562300A/en
Priority to JP2000599421A priority patent/JP2002537272A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4615—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464499—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • C12N5/064—Immunosuppressive dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GBGB9903664.2A 1999-02-17 1999-02-17 Adjuvant and cell maturation agent Ceased GB9903664D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9903664.2A GB9903664D0 (en) 1999-02-17 1999-02-17 Adjuvant and cell maturation agent
CA002362783A CA2362783A1 (en) 1999-02-17 2000-02-17 Adjuvant and cell maturation agent
EP00903870A EP1152771A2 (en) 1999-02-17 2000-02-17 Adjuvant and cell maturation agent
PCT/GB2000/000559 WO2000048631A2 (en) 1999-02-17 2000-02-17 Adjuvant and cell maturation agent
AU25623/00A AU2562300A (en) 1999-02-17 2000-02-17 Adjuvant and cell maturation agent
JP2000599421A JP2002537272A (en) 1999-02-17 2000-02-17 Adjuvants and cell maturation substances

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9903664.2A GB9903664D0 (en) 1999-02-17 1999-02-17 Adjuvant and cell maturation agent

Publications (1)

Publication Number Publication Date
GB9903664D0 true GB9903664D0 (en) 1999-04-14

Family

ID=10847985

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9903664.2A Ceased GB9903664D0 (en) 1999-02-17 1999-02-17 Adjuvant and cell maturation agent

Country Status (6)

Country Link
EP (1) EP1152771A2 (en)
JP (1) JP2002537272A (en)
AU (1) AU2562300A (en)
CA (1) CA2362783A1 (en)
GB (1) GB9903664D0 (en)
WO (1) WO2000048631A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2950109C (en) * 2000-10-27 2019-02-19 John W. Hadden Vaccine immunotherapy for immune suppressed patients
CA2555185C (en) 2004-02-06 2020-03-24 Morphosys Ag Anti-cd38 human antibodies and uses therefor
US9200061B2 (en) 2004-02-06 2015-12-01 Morpho Sys AG Generation and profiling of fully human HuCAL gold®-derived therapeutic antibodies specific for human CD3i
CN103554260A (en) 2005-10-12 2014-02-05 莫佛塞斯公司 Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2294321A (en) * 1994-10-19 1996-04-24 Yamanouchi Research Inst Method of screening for CD31 interaction inhibitors

Also Published As

Publication number Publication date
WO2000048631A3 (en) 2000-12-21
JP2002537272A (en) 2002-11-05
AU2562300A (en) 2000-09-04
EP1152771A2 (en) 2001-11-14
WO2000048631A2 (en) 2000-08-24
CA2362783A1 (en) 2000-08-24

Similar Documents

Publication Publication Date Title
EP1223932A4 (en) Compounds and methods
EP1146790A4 (en) Compounds and methods
EG23122A (en) Pyrrolcarboxamides and pyrrolcarbothioamides
AU9667901A (en) Mycoattractants and mycopesticides
EP1218133A4 (en) Display devices, accessories therefor and methods
EP1313477A4 (en) Compounds and methods
EP1274424A4 (en) Compounds and methods
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
PL332616A1 (en) Hydoxymethylhexanones as odorising and savourising agents
PL339848A1 (en) Therapeutic agent against hypephosphataemia
PL354618A1 (en) Herbicidal composition and adjuvant
GB9923344D0 (en) Foams and compositions containing these foams
EP1194147A4 (en) Arylthiazolidinedione and aryloxazolidinedione derivatives
HK1047241A1 (en) Radioprotecting agent
GB9920271D0 (en) Flavouring agent and methods for preparing and using same
GB9903664D0 (en) Adjuvant and cell maturation agent
GB9908128D0 (en) Pillow
GB9920270D0 (en) Flavouring agent and methods for preparing and using same
EP1343796A4 (en) Compounds and methods
GB0008443D0 (en) Flavourig agent and methods for preparing and using same
AU7919100A (en) Clear hair-treatment agent
GB2347298B (en) Radio telephone buzzer
GB9929581D0 (en) Comjpositions and their use
GB9911606D0 (en) Composition and use
GB9906124D0 (en) Therapeutic agent

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)